SCHEMBL6981640

SCHEMBL6981640

N#Cc1ccc(CCC(=O)N2CCCc3cc(S(=O)(=O)Cl)ccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.47
PTPN11 Q06124 1/20 0.44
ALDH1A1 P00352 9/20 0.44
LMNA P02545 4/20 0.44
TSHR P16473 3/20 0.44
MAPK1 P28482 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CYP2C9 P11712 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HTT P42858 1/20 0.43
TP53 P04637 2/20 0.43
TNF P01375 1/20 0.43
NOD2 Q9HC29 1/20 0.43
NOD1 Q9Y239 1/20 0.43
HDAC1 Q13547 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
USP2 O75604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983746 0.87 NR3C1 (0.47) NR3C1PTPN11ALDH1A1LMNATSHR
SCHEMBL6986976 0.84 ADRB2 (0.58) NR3C1ALDH1A1LMNANPSR1MEN1
SCHEMBL6985290 0.83 ALDH1A1 (0.58) ALDH1A1LMNAMAPK1CYP2C9MEN1
SCHEMBL6979722 0.83 TP53 (0.48) NR3C1ALDH1A1TSHRMAPK1MEN1
SCHEMBL6984755 0.82 TP53 (0.56) NR3C1ALDH1A1LMNAMEN1KMT2A
SCHEMBL6979462 0.82 MAPT (0.58) ALDH1A1TSHRMAPK1MEN1KMT2A
SCHEMBL7959087 0.81 TP53 (0.48) NR3C1ALDH1A1TSHRMAPK1MEN1
SCHEMBL6985865 0.81 MAPT (0.56) NR3C1ALDH1A1LMNAMEN1KMT2A
SCHEMBL6985746 0.81 KMT2A (0.56) NR3C1ALDH1A1LMNAMAPK1MEN1
SCHEMBL6982759 0.81 BRD4 (0.53) NR3C1LMNAMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed